Generated by All in One SEO v4.9.2, this is an llms.txt file, used by LLMs to index the site. # Smart Biomaterials & µ-Solutions- Smart MCs Elevating your Bioproduction ## Sitemaps - [XML Sitemap](https://smartmcs.com.au/sitemap.xml): Contains all public & indexable URLs for this website. ## Posts - [Smart MCs Team Attended ISCT Perth 2023 Conference](https://smartmcs.com.au/smart-mcs-team-attended-isct-perth-2023-conference/) - PERTH – Smart MCs, a leader in innovative biomaterials, proudly participated in the ISCT Perth 2023 Conference. The team came away both delighted and overwhelmed by the array of insightful scientific talks and poster presentations on offer. The conference proved to be an invaluable experience, offering a deep dive into the latest advancements in cell - [Addressing the Global Age-Related Macular Degeneration Crisis: Advanced Microcarrier Technology Offers Hope](https://smartmcs.com.au/addressing-the-global-age-related-macular-degeneration-crisis-advanced-microcarrier-technology-offers-hope/) - By 2040, the world is set to witness an unprecedented health challenge. Dry age-related macular degeneration (AMD) is predicted to impact a staggering 300 million individuals globally. In the face of this escalating health crisis and the current lack of viable treatments, hope emerges from ongoing clinical trials. These trials are turning to retinal pigmented - [Accelerating Vaccine Production: Unlocking Efficiency and Scale with Microcarriers](https://smartmcs.com.au/accelerating-vaccine-production-unlocking-efficiency-and-scale-with-microcarriers/) - Within the production of vaccines and similar therapeutics, microcarriers have shown to ensure significant benefit for scaling up production. Achieving the highest level of efficiency and consistent output is imperative, especially when addressing the urgent demand for widespread immunisation, combating infectious diseases, and responding to global health crises. - [Cultured Meat Officially Approved for Sale in the US](https://smartmcs.com.au/cultured-meat-officially-approved-for-sale-in-the-us/) - The United States Department of Agriculture (USDA) has announced a few days ago cultured meat products are officially approved for commercial sale in the US. This news outlines a significant step forward for the industry with the US market opened up for sale and distribution, a huge growth opportunity is prevalent for this emerging sector. - [Stem Cells Proposed as Key Component in the Treatment of Multiple Sclerosis](https://smartmcs.com.au/stem-cells-proposed-as-key-component-in-the-treatment-of-multiple-sclerosis/) - Multiple leading scientists have suggested stem cells as a key component in Autologous Hematopoietic Stem Cell Transplantation (AHSCT) as a potential treatment for Multiple Sclerosis (MS). Such therapies can be enhanced from scaled production through cell microcarriers. - [The Role of Microcarriers in Advancing Exosome Production from Stem Cells](https://smartmcs.com.au/the-role-of-microcarriers-in-advancing-exosome-production-from-stem-cells/) - Various studies have identified the increasingly prevalent advantages of microcarriers when used in the production of Extracellular Vesicles (EVs), in particular, exosomes. This article gives a summary of these respective studies, pointing to the increasing value microcarriers play in scaled production of exosomes. - [Happy New Year 2026 from Smart MCs](https://smartmcs.com.au/happy-new-year-2026-from-smart-mcs/) - As we step into 2026, we’d like to thank everyone who worked with Smart MCs over the past year and supported our journey. We remain focused on doing our work well, maintaining high standards, and building long-term relationships with our customers and partners across the biotechnology and research sectors. Thank You Thank you to our - [Peptide-Functionalised Alginate Hydrogels Help Stem Cells Survive Stress and Reduce Inflammation](https://smartmcs.com.au/peptide-functionalised-alginate-hydrogels-help-stem-cells-survive-stress-and-reduce-inflammation/) - A brief look at recent work by Tan et al., 2025 The Problem: Stem Cells Struggle in Harsh, Inflamed Environments Mesenchymal stem cells (MSCs) are widely studied because they can reduce inflammation and help damaged tissues repair themselves. They’re being explored for conditions such as arthritis, spinal disc degeneration, and chronic inflammation. But there’s a - [How Microfluidic Hydrogel Microcarriers Improve Exosome Delivery in Osteoarthritis Research](https://smartmcs.com.au/how-microfluidic-hydrogel-microcarriers-improve-exosome-delivery-in-osteoarthritis-research/) - In a paper published by Yang and colleagues, titled “Stem cell recruitment polypeptide hydrogel microcarriers with exosome delivery for osteoarthritis treatment” in the Journal of Nanobiotechnology (2024), the authors describe a hydrogel microcarrier system designed to improve exosome delivery and support cartilage repair. Their work demonstrates how microfluidic fabrication and biomaterial engineering can help overcome - [How Researchers Compared Standard Microcarriers to GelMA Microcarriers: A Simple Breakdown](https://smartmcs.com.au/how-researchers-compared-standard-microcarriers-to-gelma-microcarriers-a-simple-breakdown/) - Microcarriers are tiny spherical materials used to grow cells in 3D, especially when large numbers of cells are needed. A recent study explored how a commonly used commercial microcarrier compared with newly developed GelMA-based microcarriers that contain interconnected pores. This comparison helps illustrate how microcarrier design can influence cell behaviour. A recent study titled “Dual - [How Collagen Coatings Improve Microcarriers for Mesenchymal Stem Cell Expansion](https://smartmcs.com.au/how-collagen-coatings-improve-microcarriers-for-mesenchymal-stem-cell-expansion/) - The Growing Role of Microcarriers in Cell Culture In regenerative medicine, cell therapy, and cultivated meat production, mesenchymal stem cells (MSCs) are vital for creating tissues like bone, cartilage, and muscle. However, producing these cells at a large scale is challenging because MSCs must attach to a surface to grow. To overcome this limitation, researchers - [How Microcarrier Stiffness Shapes Cell Growth and Identity: New Insights for Scalable Cell Culture](https://smartmcs.com.au/how-microcarrier-stiffness-shapes-cell-growth-and-identity-new-insights-for-scalable-cell-culture/) - The Science Behind Cell–Material Interactions In large-scale cell culture and regenerative medicine, microcarriers are essential for expanding adherent cells in suspension bioreactors. A 2025 study in the Chemical Engineering Journal by Tian et al. revealed that the mechanical stiffness of these carriers directly influences how human amniotic epithelial cells (hAECs) grow and maintain their identity - [Microcarriers for Scalable MSC Exosome Production: What a Recent Study Found](https://smartmcs.com.au/microcarriers-for-scalable-msc-exosome-production-what-a-recent-study-found/) - A 2025 BMC Veterinary Research study shows how microcarriers in spinner flasks enable scalable MSC exosome production with ~81 nm size, stable charge, and high particle yield plus storage, bioactivity, and safety insights. In a recent study… Title: Scalable production of anti-inflammatory exosomes from three-dimensional cultures of canine adipose-derived mesenchymal stem cells: production, stability, bioactivity, - [September'2025 – Scientific Webinar: Prof. Kristopher Kilian](https://smartmcs.com.au/september2025-scientific-webinar-prof-kristopher-kilian/) - We were pleased to host Prof. Kristopher Kilian from UNSW Sydney for our September webinar, where he presented on: Inspired by Nature: Biomaterials Design for Therapeutic Cell Production and Delivery Presentation Highlights Supramolecular, self-healing hydrogels: Prof. Kilian presented Trpzip hydrogels with tuneable mechanics, low yield point, shear-thinning, and self-healing behaviour, along with stress relaxation similar - [The Role of Microcarriers in Cartilage Regeneration: From Research to Application](https://smartmcs.com.au/the-role-of-microcarriers-in-cartilage-regeneration-from-research-to-application/) - Did you know that microcarriers are not only used for large-scale cell expansion, but also for therapeutic regeneration? A recent communication in Materials Horizons by Na-Hyun Lee, Hye Sung Kim, Hae-Won Kim, and colleagues (Dankook University, South Korea), titled “Chondrocyte-mimetic therapeutic microcarriers for synergistic chemo-mechanical signaling in cartilage regeneration,” reports chondrocyte-mimetic therapeutic microcarriers that recapitulate - [Cultivated Fish Meat and the Future of Microcarriers](https://smartmcs.com.au/cultivated-fish-meat-and-the-future-of-microcarriers/) - The global demand for seafood continues to climb. Yet overfishing, habitat destruction, and pollution from heavy metals and microplastics make traditional fishing and aquaculture less sustainable every year. One of the most exciting solutions to this challenge is cell-based fish meat, grown directly from fish cells in bioreactors, without needing to raise or harvest whole - [Smart MCs × TCS | July 2025 Scientific Webinar with Dr. Daniel Peters](https://smartmcs.com.au/smart-mcs-x-tcs-july-2025-scientific-webinar-with-dr-daniel-peters/) - Building a Molecular “Lego Set” to Solve the Challenges of Cell Culture We were pleased to welcome Dr. Daniel Peters, CEO and co-founder of MarraBio Ltd, for our July 2025 Smart MCs Webinar, held in collaboration with TCS Biosciences. In this engaging session, Dan introduced a revolutionary approach to mammalian cell culture using engineered protein - [Peer-Reviewed Study Confirms Smart MCs’ Customisable, Dissolvable Microcarriers Enable Scalable, High-Yield Cell Production](https://smartmcs.com.au/peer-reviewed-study-confirms-smart-mcs-customisable-dissolvable-microcarriers-enable-scalable-high-yield-cell-production/) - A newly published study in Biomedical Materials validates Smart MCs’ X1 microcarriers, a fully customisable and dissolvable platform for large-scale adherent cell culture. The gelatin-based carriers were shown to outperform a widely used commercial benchmark across multiple sectors, including cultivated meat, regenerative medicine, and vaccine production. This article breaks down what X1 microcarriers are, why - [Scalable Dengue Vaccine Production Using Vero Cells and Microcarriers](https://smartmcs.com.au/scalable-dengue-vaccine-production-using-vero-cells-and-microcarriers/) - Dengue fever is a serious mosquito-borne illness that affects hundreds of millions of people each year, particularly across Asia, the Pacific, and parts of Australia. There are four types of dengue virus, known as DENV1, DENV2, DENV3, and DENV4. A person can be infected with each type only once, and catching one doesn’t protect you - [NIH Ends Funding for Animal-Only Studies: What the FDA-NIH Workshop Means for the Future of Non-Animal Testing](https://smartmcs.com.au/nih-ends-funding-for-animal-only-studies-what-the-fda-nih-workshop-means-for-the-future-of-non-animal-testing/) - A pivotal shift toward human-relevant science, regulatory alignment, and the adoption of New Approach Methodologies (NAMs) In July 2025, the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) jointly hosted the FDA-NIH Workshop: Reducing Animal Testing, a pivotal event in biomedical research policy. With broad participation from regulatory bodies, industry - [Smart MCs and UNSW Awarded ARC Linkage Grant to Advance Customisable Microcarrier Technology for Biomanufacturing](https://smartmcs.com.au/smart-mcs-and-unsw-awarded-arc-linkage-grant-to-advance-customisable-microcarrier-technology-for-biomanufacturing/) - Smart MCs Pty Ltd is proud to announce its participation in a $900,000 research collaboration with the University of New South Wales (UNSW), supported by $900,000 in funding through the Australian Research Council (ARC) Linkage Program. This project is led by A/Prof. Christopher Marquis and Prof. Kris Kilian at UNSW. The project will focus on - [June'2025 - Scientific Webinar: A/Prof. Khoon Lim](https://smartmcs.com.au/june2025-scientific-webinar-a-prof-khoon-lim/) - We were pleased to host A/Prof. Khoon Lim from the University of Sydney for our June webinar, where he presented on: Light-Activated Biomaterials as Bioinks for 3D Printing Presentation Highlights Hydrogel Development for 3D Bioprinting: A/Prof. Khoon Lim discussed his group’s work on hydrogel-based biomaterials, focusing on gelatin and synthetic polymers like polyvinyl alcohol for - [Expanding Stem Cells Efficiently: New Research Shows Why Microcarriers Matter](https://smartmcs.com.au/expanding-stem-cells-efficiently-new-research-shows-why-microcarriers-matter/) - A new study led by Shiina Pasanen and colleagues, published in the Biotechnology Journal (2025), demonstrates a powerful approach to expanding human mesenchymal stem cells (hMSCs) using microcarrier-based systems. Although the team used custom-engineered microcarriers, the results strongly support the broader use of microcarriers in regenerative medicine and scalable cell manufacturing. The Challenge: Scaling Up - [Smart MCs to Present on Microcarrier Commercialisation at OzNanoMed 2025](https://smartmcs.com.au/smart-mcs-to-present-on-microcarrier-commercialisation-at-oznanomed-2025/) - Smart MCs is proud to share that our Chief Technology Officer, Dr. Lin Ding, presented at the 15th International NanoMedicine Conference (OzNanoMed 2025), held from 16–18 June at the Pier One Sydney Harbour Hotel in Sydney. On Tuesday, 17 June at 2:15 PM (AEST), Lin delivered a talk titled “Redraw Our Roadmap with Customer Voices: - [Smart MCs to Present Poster at ISSCR 2025 in Hong Kong](https://smartmcs.com.au/smart-mcs-to-present-poster-at-isscr-2025-in-hong-kong/) - We’re proud to announce that Smart MCs will be presenting a research poster at the ISSCR 2025 Annual Meeting, taking place 11–14 June 2025 at the Hong Kong Convention and Exhibition Centre. Organised by the International Society for Stem Cell Research, ISSCR 2025 is one of the world’s leading conferences for stem cell science and - [Scalable Production of MSC-Derived Extracellular Vesicles Using Microcarrier-Based Stirred-Tank Reactors](https://smartmcs.com.au/scalable-production-of-msc-derived-extracellular-vesicles-using-microcarrier-based-stirred-tank-reactors/) - A recent study by Ulpiano et al., published in Stem Cell Research & Therapy (2025), presents a fully scalable, Good Manufacturing Practice (GMP)-compliant platform for producing extracellular vesicles (EVs) derived from human mesenchymal stromal cells (MSCs). The platform uses microcarrier-based stirred-tank reactors (STRs) combined with advanced purification methods to enable continuous, large-scale production of clinical-grade - [Study Finds Microcarrier-Cultured MSC-EVs Show Greater Potency Against Autoimmune Uveitis](https://smartmcs.com.au/study-finds-microcarrier-cultured-msc-evs-show-greater-potency-against-autoimmune-uveitis/) - Published in the Journal of Extracellular Vesicles, May 2024 Lead author: Dr. Gagandeep Kaur A study published in the Journal of Extracellular Vesicles reports that extracellular vesicles (EVs) derived from mesenchymal stem/stromal cells (MSCs) using microcarrier-based cultures are more effective in suppressing immune responses than those from conventional monolayer cultures. The researchers also found that - [Smart MCs Poster at ISCT 2025 - New Orleons](https://smartmcs.com.au/smart-mcs-poster-at-isct-2025-new-orleons/) - We are excited to announce that our Scientific Advisor, Prof. Steve Oh, will be attending and presenting the latest research findings on Smart MCs’ innovative P2 dissolvable microcarriers at the upcoming ISCT 2025 conference in New Orleans. Prof. Oh’s presentation will highlight the significant advancements made possible by the unique properties of our P2 microcarriers, - [Treatment for Age-Related Hearing Loss: The Role of MSCs and Extracellular Vesicles](https://smartmcs.com.au/treatment-for-age-related-hearing-loss-the-role-of-mscs-and-extracellular-vesicles/) - As we age, hearing loss becomes more common—and frustrating. It’s not just about turning up the volume; it’s about tiny, delicate cells in our ears that get damaged and don’t grow back. Scientists are now exploring how stem cells and their “messenger bubbles” (called EVs) might actually help the body repair itself. This could mean - [What We Learned from RoosterBio’s Webinar on MSC-Derived EVs](https://smartmcs.com.au/what-we-learned-from-roosterbios-webinar-on-msc-derived-evs/) - RoosterBio, Inc. recently hosted a webinar titled Exploring MSC-EV Attributes: Analytical Comparison of Tissue Sources & Production Platforms. In this session, Dr. Elie Zakhem (Associate Director, Analytical Development and Services) and Dr. Stephen Lenzini (Senior Scientist) presented key insights on how different tissue sources and production platforms shape the characteristics of mesenchymal stem cell (MSC)-derived - [Smart MCs Partners with $271M AMCRC to Help Shape the Future of Australian Manufacturing](https://smartmcs.com.au/smart-mcs-partners-with-271m-amcrc-to-help-shape-the-future-of-australian-manufacturing/) - Smart MCs is a partner in the newly launched Additive Manufacturing Cooperative Research Centre (AMCRC) — a $271 million national initiative focused on transforming and strengthening Australia’s manufacturing capabilities through additive manufacturing (3D printing). The AMCRC brings together more than 100 organisations from across research, industry, and government. Some of the key partners include: Boeing - [Smart MCs Joins $238M National Initiative to Power Australia's Future of Regenerative Therapy Manufacturing](https://smartmcs.com.au/smart-mcs-joins-238m-national-initiative-to-power-australias-future-of-regenerative-therapy-manufacturing/) - Smart MCs is proud to be a core partner in the $238 million SMART CRC (Solutions for Manufacturing Advanced Regenerative Therapies), a new national research centre hosted by The University of Queensland. This transformative initiative brings together more than 60 partners from across Australia’s research, biotech, and healthcare sectors to advance the way regenerative therapies - [April'2025 - Scientific Webinar: A/Prof. Reza Nosrati](https://smartmcs.com.au/april2025-scientific-webinar-a-prof-reza-nosrati/) - We were pleased to host A/Prof. Reza Nosrati from Monash University for our April webinar, where he presented on: From Engineering Reproduction to Navigating the Academic Path Presentation Highlights Paper-based Sperm Assays – Low-cost diagnostic tools detecting live sperm motility and concentration. AI-Powered Morphology Analysis – Real-time, label-free sperm classification using ensemble machine learning. Virtual - [FDA Plans to Phase Out Animal Testing for Monoclonal Antibodies — What It Means for the Future of Drug Development](https://smartmcs.com.au/fda-plans-to-phase-out-animal-testing-for-monoclonal-antibodies-what-it-means-for-the-future-of-drug-development/) - The United States Food and Drug Administration (FDA) recently announced a significant policy change. The FDA plans to phase out its requirement for animal testing in the safety evaluation of certain medicines, including monoclonal antibodies (mAbs). This change reflects the FDA’s effort to update drug testing practices with methods that are more relevant to human - [March'2025 - Scientific Webinar: A/Prof. Lana McClements](https://smartmcs.com.au/march2025-scientific-webinar-prof-lana-mcclements/) - We were pleased to host A/Prof. Lana McClements from the University of Technology Sydney for our March webinar, where she presented on: 3D Modelling of Tissues Relevant to Reproductive Health Presentation Highlights 3D Bioprinted Placental Organoids – Used to model placental development and pregnancy complications. Placenta-on-a-Chip – A microfluidic system replicating placental function and preeclampsia. - [Mesenchymal Stem Cell Isolation Protocol](https://smartmcs.com.au/mesenchymal-stem-cell-isolation-protocol/) - The following protocols for isolating Mesenchymal Stem Cells (MSCs) are adapted and simplified by FUJIFILM Irvine Scientific from published reports. Please note that these protocols have not been validated by Smart MCs and are provided for reference purposes only. For additional MSC-related protocols and reagents, please visit the FUJIFILM Irvine Scientific website. You can view - [Smart MCs Exhibiting at the 2025 Advanced Therapies Congress in London](https://smartmcs.com.au/smart-mcs-exhibiting-at-the-2025-advanced-therapies-congress-in-london/) - We are pleased to announce that Smart MCs will be exhibiting at the Advanced Therapies Congress 2025, taking place on March 18-19, 2025, at ExCeL London. Recognised as Europe’s largest commercial cell and gene therapy event, this congress is a key meeting point for experts, researchers, and industry leaders who are shaping the future of - [5 Essential Tips for Small-Scale Microcarrier Culture](https://smartmcs.com.au/5-essential-tips-for-small-scale-microcarrier-culture/) - Small-scale microcarrier cultures play a crucial role in process development, allowing researchers to refine conditions before scaling up to larger bioreactors. However, managing small-scale cultures requires careful optimisation to ensure reliable and reproducible results. Here are five essential tips to enhance your small-scale microcarrier culture and set the foundation for successful scale-up. Use a Non-Adherent - [3D Scaffold-Derived Exosomes for Cartilage Repair](https://smartmcs.com.au/3d-scaffold-derived-exosomes-for-cartilage-repair/) - Cartilage injuries are difficult to treat due to the tissue’s limited ability to regenerate. Unlike other tissues, cartilage lacks blood vessels, nerves, and lymphatic supply, which are essential for delivering nutrients and immune cells to support healing. As a result, damaged cartilage often fails to repair itself, leading to degeneration and conditions such as osteoarthritis. - [February’2025 – Scientific Webinar: Prof. Majid Ebrahimi Warkiani](https://smartmcs.com.au/monthly-scientific-webinar-dr-majid-ebrahimi-warkiani/) - We were honored to host Prof. Majid Ebrahimi Warkiani for our February webinar, where he presented on: Microfluidic Systems for Cell Biology and Translation into Practice Presentation Highlights What is Microfluidics?Prof. Warkiani explored how microfluidic platforms enable precise manipulation of fluids at the microscale, creating controlled cellular environments that enhance biomedical research and clinical applications. - [The Impact of ECM Stiffness on MSC Differentiation – Why Stiffness Matters in Your Cell Culture](https://smartmcs.com.au/the-impact-of-ecm-stiffness-on-msc-differentiation-why-stiffness-matters-in-your-cell-culture/) - The mechanical properties of the extracellular matrix (ECM) play a crucial role in directing stem cell fate. According to the research by Na et al. (2024), published in Biomaterials, mesenchymal stem cells (MSCs) cultured on ECMs with different stiffness levels show significant differences in chromatin organisation and gene expression, ultimately driving lineage-specific differentiation. This study - [What ISCT Says About the Landmark FDA Approval of Allogeneic MSCs](https://smartmcs.com.au/what-isct-says-about-the-landmark-fda-approval-of-allogeneic-mscs/) - The recent FDA approval of Mesoblast’s Ryoncil™, an allogeneic bone-marrow mesenchymal stromal cell (MSC) therapy, marks a significant milestone in regenerative medicine and cell therapy. This long-anticipated decision provides new hope for patients with steroid-refractory acute Graft-versus-Host Disease (GvHD) and sets a regulatory precedent for future MSC-based therapies worldwide. The International Society for Cell & - [January'2025 - Scientific Webinar: Prof. Steve Oh](https://smartmcs.com.au/january25-scientific-webinar-prof-steve-oh/) - We were honored to host Prof. Steve Oh for our January webinar, where he presented on: “Mesenchymal Stem Cell Therapies: Promises Fulfilled and Potential New Applications.” Presentation Highlights: What are MSCs?Prof. Oh explored the unique capabilities of Mesenchymal Stromal Cells (MSC), also referred to as Medicinal Signaling Cells, for their ability to produce cytokines, growth - [Smart MCs Partners with TCS Biosciences to Expand Access to Research Tools in the UK and Europe](https://smartmcs.com.au/smart-mcs-partners-with-tcs-biosciences-to-expand-access-to-research-tools-in-the-uk-and-europe/) - We are excited to announce our partnership with TCS Biosciences Ltd, a trusted leader in laboratory reagents and test kits, now serving as the official distributor of Smart MCs products in the UK and Europe. This partnership will make our smart microcarriers, hydrogels, and microfluidics tools more accessible to researchers across these regions. About TCS - [Improving Adherent Cell Culture with Microcarriers in a Funnel-Type Fluidized Bed Reactor](https://smartmcs.com.au/improving-adherent-cell-culture-with-microcarriers-in-a-funnel-type-fluidized-bed-reactor/) - Adherent cell culture is essential for many biotechnological applications, including stem cell expansion, vaccine production, and therapeutic manufacturing. A recent study by Seohyun Park, Hyunwoo Kim, and Duk Jae Oh, published in Biotechnology and Bioprocess Engineering (2024), introduces a funnel-type fluidized bed reactor that improves the efficiency and stability of microcarrier-based cell culture systems. Challenges - [Happy New Year 2025 from Smart MCs! 🎉](https://smartmcs.com.au/happy-new-year-2025-from-smart-mcs-🎉/) - As we close the chapter on 2024 and welcome the opportunities of 2025, we take a moment to reflect on the journey, celebrate achievements, and express our sincere gratitude to everyone who has been part of it. 2024: A Year of Innovation and Progress This past year has been a pivotal one for Smart MCs. - [FDA Approves First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease](https://smartmcs.com.au/fda-approves-first-mesenchymal-stromal-cell-therapy-for-steroid-refractory-acute-graft-versus-host-disease/) - The FDA has approved Ryoncil (remestemcel-L-rknd), the first mesenchymal stromal cell (MSC) therapy for steroid-refractory acute graft-versus-host disease (SR-aGVHD) in pediatric patients aged two months and older. This approval is a monumental milestone for regenerative medicine, offering a critical treatment option for a condition with limited alternatives and setting the stage for further innovation in - [Serum-Free Cell Culture with Microbial Lysates: A Cost-Effective Solution for Scalable Growth](https://smartmcs.com.au/serum-free-cell-culture-with-microbial-lysates-a-cost-effective-solution-for-scalable-growth/) - The cell culture industry is evolving to meet the growing demand for cultivated meat, also referred to as lab-grown or cultured meat. This innovative approach produces meat by growing animal cells in controlled environments, bypassing the need for traditional farming. Cultivated meat has the potential to address key global challenges, including reducing greenhouse gas emissions, - [5 Essential Tips for Optimising Agitation in Your Microcarrier Culture](https://smartmcs.com.au/5-essential-tips-for-optimising-agitation-in-your-microcarrier-culture/) - Agitation is a cornerstone of successful microcarrier-based cell culture, ensuring uniform mixing, nutrient distribution, and oxygenation. However, improper agitation can lead to issues such as aggregate formation or cell damage. Here are five focused tips to help you optimise agitation and achieve consistent results in your microcarrier culture. Know Your Context Different cell types have - [Cultured Meat News: Vow’s Forged Gras](https://smartmcs.com.au/cultured-meat-news-vows-forged-gras/) - The future of food innovation is here, and companies like Vow are paving the way with revolutionary products like Forged Gras, a cultured twist on the controversial delicacy foie gras. Launched in New York City, Forged Gras is bringing foie gras back to menus worldwide—ethically and sustainably. This milestone highlights how cultured meat is evolving, - [Why Customisable Microcarriers Are Essential for Scalable Cultured Meat Production](https://smartmcs.com.au/why-customisable-microcarriers-are-essential-for-scalable-cultured-meat-production/) - In the cultured meat industry, scalability and optimised cell culture processes are crucial for commercial success. Microcarriers (MCs) offer a reliable solution for achieving high cell densities, making them essential in producing large volumes of cells needed for cultivated meat. However, customization of microcarriers is key to maximising their effectiveness, particularly when working in serum-free - [How iPSCs Are Changing the Game in Treating Corneal Endothelial Dysfunction](https://smartmcs.com.au/how-ipscs-are-changing-the-game-in-treating-corneal-endothelial-dysfunction/) - Corneal endothelial dysfunction (CED), which leads to vision impairment and corneal edema, has traditionally been managed through corneal transplants. Yet, with donor corneas in short supply, researchers have been exploring alternative solutions. Now, induced pluripotent stem cells (iPSCs) are emerging as a promising source of corneal endothelial cells (CECs), offering a renewable approach that could - [Microbeads for Functional Food Ingredient Delivery](https://smartmcs.com.au/microbeads-for-functional-food-ingredient-delivery/) - Did you know that microbeads or microcarriers can transform the delivery of functional food ingredients? These tiny, natural carriers, made from pectin and chitosan, are designed to protect sensitive nutrients like probiotics, vitamins, and other bioactive compounds from the harsh conditions of the stomach. A recent study published in Foods (2024) reveals the potential of - [5 Essential Tips to Promote Cell Attachment in Your Microcarrier Culture](https://smartmcs.com.au/5-essential-tips-to-promote-cell-attachment-in-your-microcarrier-culture/) - As the demand for scalable cell culture systems increases, microcarrier cultures have become a popular choice for bioprocessing and tissue engineering. However, achieving strong cell attachment is critical for success. Whether you’re scaling up production or experimenting in the lab, these five key tips will help you enhance cell attachment and improve your outcomes. 1. - [Bioprocess Development for eCB-MSCs Expansion Using Microcarriers](https://smartmcs.com.au/bioprocess-development-for-ecb-mscs-expansion-using-microcarriers/) - Recent advancements in cell-based therapies highlight the potential of mesenchymal stromal cells (MSCs) to address various medical challenges. Equine cord blood-derived MSCs (eCB-MSCs), known for their regenerative and immunomodulatory abilities, are particularly promising for veterinary applications. Efficient expansion of these cells is crucial to meet therapeutic demands, a task not adequately met by traditional static - [Innovative Injectable Microcarrier-Hydrogel Composite for Dental Stem Cell Delivery and Tissue Regeneration](https://smartmcs.com.au/innovative-injectable-microcarrier-hydrogel-composite-for-dental-stem-cell-delivery-and-tissue-regeneration/) - A new study introduces an advanced approach for dental tissue regeneration using an injectable microcarrier-hydrogel composite system. This method aims to address the limitations of conventional stem cell therapies, particularly the challenges of low cell viability and poor integration after transplantation. By combining dental pulp stem cells (DPSCs) with a composite of gelatin methacrylate (GelMA) - [PhD Opportunity: Research in Animal-Free Hydrogels](https://smartmcs.com.au/phd-opportunity-research-in-animal-free-hydrogels/) - In partnership with UNSW, we are excited to offer a fully funded PhD position focused on developing animal-free hydrogels for organoid culture and drug screening. This multidisciplinary project integrates biochemistry and cell biology to create innovative synthetic and natural polymer hydrogels, contributing to advancements in regenerative medicine and pharmacology. Project Overview The PhD candidate will - [Top 12 Mistakes to AVOID When Using Microcarriers](https://smartmcs.com.au/top-12-mistakes-to-avoid-when-using-microcarriers/) - Microcarrier culture is a powerful tool for large-scale cell production, but it requires careful attention to detail to avoid common mistakes that can compromise the quality and efficiency of your culture. From seeding to harvesting, each step presents its own challenges that, if not managed properly, can lead to suboptimal results. Inconsistent Seeding Due to - [Advancements in Scalable SARS-CoV-2 Vaccine Production: The Role of Microcarrier-Based Cultures](https://smartmcs.com.au/advancements-in-scalable-sars-cov-2-vaccine-production-the-role-of-microcarrier-based-cultures/) - In a recent publication, researchers have made significant advancements in the scalable production of viral vectors for SARS-CoV-2 vaccines. By leveraging microcarrier-based cell culture in stirred-tank bioreactors, this method offers an efficient and cost-effective solution for lab-based vaccine production. These innovations are essential for addressing the urgent need for rapid vaccine development, particularly during global - [Harnessing Microcarrier Culture for Large-Scale Screening of Active Compounds Acting on FGFR4 Using HEK293T Cells](https://smartmcs.com.au/harnessing-microcarrier-culture-for-large-scale-screening-of-active-compounds-acting-on-fgfr4-using-hek293t-cells/) - One of the most significant advancements in drug discovery is the ability to screen bioactive compounds effectively and at scale. This is particularly important when using cells like HEK293T cells, which are difficult to produce at scale. A recent study published in the Journal of Pharmaceutical and Biomedical Analysis demonstrates how microcarrier culture can solve - [Cutting-Edge Microbioreactor Approach Enhances MSC Yield and Potency for Therapies](https://smartmcs.com.au/cutting-edge-microbioreactor-approach-enhances-msc-yield-and-potency-for-therapies/) - In a recent study, researchers have developed a novel microcarrier-microbioreactor platform that shows significant promise for improving the manufacturing process of mesenchymal stem and stromal cells (MSCs), which are vital for treating a range of clinical conditions. Despite the potential of MSCs, their clinical application has been hindered by challenges in achieving consistent product quality, - [Intensified Process Development for hiPSC-Based Therapeutics Demonstrates Improved Efficiency and Cell Quality](https://smartmcs.com.au/intensified-process-development-for-hipsc-based-therapeutics-demonstrates-improved-efficiency-and-cell-quality/) - A recent study has shed light on a novel process intensification strategy for the expansion of human induced pluripotent stem cells (hiPSCs), which holds promise for enhancing the manufacturing of hiPSC-based therapeutics. The research focused on evaluating a one-step inoculation (OSI) approach, commonly used in antibody and vaccine production, and its potential application to hiPSC - [Innovative Process for Large-Scale Expansion of Wharton’s Jelly Mesenchymal Stem Cells](https://smartmcs.com.au/innovative-process-for-large-scale-expansion-of-whartons-jelly-mesenchymal-stem-cells/) - Wharton’s jelly mesenchymal stem/stromal cells (WJMSCs) have gained significant attention due to their potential in immunomodulatory, anti-inflammatory, tissue repair, and regenerative therapies. These cells have shown promise in treating various clinical conditions, highlighting the need for scalable manufacturing processes to meet commercial and clinical demands. Recent research has focused on developing a robust, scalable, and - [Webinar Announcement: Bioprocessing and Artificial Intelligence in Cell Therapies - China’s Model](https://smartmcs.com.au/webinar-announcement-bioprocessing-and-artificial-intelligence-in-cell-therapies-chinas-model/) - We are excited to announce that our Chief Scientific Advisor, Prof. Steve Oh, PhD, will be chairing an insightful webinar on “Bioprocessing and Artificial Intelligence in Cell Therapies: China’s Model.” This event is presented by the ISCT Asia Regional Executive Committee and sponsored by REGEN-αGEEK (Haining) Biotechnology Co., Ltd. Event Details: Date: Wednesday, August 7, - [High-yield Production of Inactivated Influenza H5N1 Vaccines from MDCK Cells using Microcarriers](https://smartmcs.com.au/high-yield-production-of-inactivated-influenza-h5n1-vaccines-from-mdck-cells-using-microcarriers/) - Influenza viruses pose a significant threat to global health, with the potential to trigger pandemics. Vaccination remains the primary strategy to reduce illness and death during such outbreaks. Addressing the urgent need for readily available vaccines, a new study introduces an advanced manufacturing process for inactivated influenza H5N1 vaccines. This innovative process leverages Madin-Darby canine - [Scaling Bovine Viral Vaccine Production with Innovative Bioreactor Technology](https://smartmcs.com.au/scaling-bovine-viral-vaccine-production-with-innovative-bioreactor-technology/) - Check out this publication on how scaling bovine viral vaccine production can be enabled using Microcarriers: Vaccination remains the most effective method for controlling and preventing diseases, ensuring the safe trade of live animals. The manufacturing of viral vaccines, however, comes with specific challenges, particularly due to the demands of the cell substrates and viral - [Advancing Gene Therapy: Enhancing AAV Vector Production with Microcarrier-Based Cultures](https://smartmcs.com.au/advancing-gene-therapy-enhancing-aav-vector-production-with-microcarrier-based-cultures/) - Adeno-associated virus (AAV) vectors are at the forefront of gene therapy, offering great potential for treating a variety of genetic disorders. However, a significant challenge in the field is the limited production capacity of these vectors. Higher specific yields of AAV vectors are often achieved using adherent cell systems compared to suspension cultures, and microcarrier-based - [Smart MCs Poster at ISSCR Annual Meeting](https://smartmcs.com.au/smart-mcs-poster-at-isscr-annual-meeting/) - Recently, Smart MCs’ advisor, Prof. Steve Oh, attended the International Society for Stem Cell Research (ISSCR) Annual Meeting in Hamburg, Germany, on our behalf and presented our poster. ISSCR is a global non-profit organization dedicated to advancing stem cell science and regenerative medicine. It brings together researchers, clinicians, educators, and industry professionals to promote knowledge - [Impact of Extracellular Matrix Stiffness and Shear Stress on Myoblast Regeneration: New Insights from Recent Study](https://smartmcs.com.au/impact-of-extracellular-matrix-stiffness-and-shear-stress-on-myoblast-regeneration-new-insights-from-recent-study/) - Introduction Recent research has shed light on the crucial factors affecting myoblast regeneration, a key process in muscle repair. Myoblasts, the precursor cells to muscle fibers, are subjected to mechanical forces such as shear stress during muscle regeneration. This study aimed to explore how these mechanical forces, combined with changes in the extracellular matrix (ECM) - [Scalable Manufacturing of Gene-Modified Human Mesenchymal Stromal Cells with Microcarriers in Spinner Flasks](https://smartmcs.com.au/scalable-manufacturing-of-gene-modified-human-mesenchymal-stromal-cells-with-microcarriers-in-spinner-flasks/) - A recent publication titled “Scalable manufacturing of gene-modified human mesenchymal stromal cells with microcarriers in spinner flasks” in the Journal of Biotechnological Products and Process Engineering addresses a critical challenge in gene-modified cell therapy: developing scalable manufacturing methods for clinical applications. Human mesenchymal stromal cells (hMSCs) are known for their immunomodulatory properties and in vitro - [Exploring Cutting-Edge Cancer Treatment Models: The Role of Organoids and Organs-on-a-Chip](https://smartmcs.com.au/exploring-cutting-edge-cancer-treatment-models-the-role-of-organoids-and-organs-on-a-chip/) - Cancer treatment faces a multitude of challenges, notably the variation in tumor behavior across different patients. This heterogeneity necessitates personalized approaches to treatment that can adapt to the unique characteristics of each patient’s cancer. Recently, a review article shed light on innovative laboratory models that could be key to advancing these personalized treatments: organoids and - [Large-Scale Microcarrier Culture for Animal Viral Vaccine Production](https://smartmcs.com.au/large-scale-microcarrier-culture-revolutionizes-viral-vaccine-production/) - Mandarin fish (Siniperca chuatsi) holds a crucial position in China’s aquaculture industry. Yet, the persistent threats posed by Infectious Spleen and Kidney Necrosis Virus (ISKNV) and Siniperca Chuatsi Rhabdovirus (SCRV) have hampered its growth potential. Vaccination stands as the most potent defense, but its efficacy hinges on large-scale cell culture—a challenge until now. In a - [Smart MCs Announces New Partnership with Macquarie University](https://smartmcs.com.au/smart-mcs-announces-new-partnership-with-macquarie-university/) - We are thrilled to share exciting news at Smart MCs! A pioneering partnership has been forged with Macquarie University, focusing on the development of an AI-based predictive model for the reliability assessment of microcarriers. This collaborative project is part of a pilot research initiative, generously funded by both Smart MCs and Macquarie University under the - [Reconstructing the Heart with iPSCs: Insights and Innovations](https://smartmcs.com.au/reconstructing-the-heart-with-ipscs-insights-and-innovations/) - Recent research spearheaded by Stanford scholars has shed light on the pioneering use of induced pluripotent stem cells (iPSCs) in cardiac tissue engineering (Link to Source Article). This innovative approach not only promises to revolutionize our understanding of cardiovascular diseases but also paves the way for new therapeutic strategies. Here’s what you need to know - [Scalable Expansion of iPSCs Technology Using Microcarrier Cultures](https://smartmcs.com.au/scalable-expansion-of-ipscs-technology-using-microcarrier-cultures/) - Induced pluripotent stem cells (iPSCs) represent a cornerstone in regenerative medicine and biotechnological research. These versatile cells are generated from somatic cells and can differentiate into nearly any cell type, making them invaluable for applications such as disease modeling, drug testing, and potentially, organ regeneration. Recognizing their potential, the European Bank for induced pluripotent Stem - [The Power of Functional Polymer Surfaces in Controlling Cell Behaviors](https://smartmcs.com.au/the-power-of-functional-polymer-surfaces-in-controlling-cell-behaviors/) - A recent review publication has shed light on the monumental potential of functional polymer surfaces in steering cell behavior, marking a significant advancement in the realms of biomedical engineering, tissue engineering, and cell-based assays. This paper, freely accessible online, delves into the critical role artificial extracellular matrices (ECMs) play in emulating natural processes to control - [Enhancing the Palatability of Cultivated Meat: A Review](https://smartmcs.com.au/enhancing-the-palatability-of-cultivated-meat-a-review/) - We are pleased to announce the publication of a significant review by our very own Dr. Christopher J. O’Keeffe, in collaboration with esteemed scientists from the University of Sydney, University of New South Wales, and University of the Sunshine Coast. This review, published in the prestigious journal Trends in Biotechnology, focuses on a crucial aspect - [Revolutionising Vaccine Manufacturing: Insights from a Study on Microcarrier-Based Cell Culture](https://smartmcs.com.au/revolutionising-vaccine-manufacturing-insights-from-a-study-on-microcarrier-based-cell-culture/) - In the realm of biotechnology, the quest for more efficient methods to cultivate cells for vaccine production is ongoing. A recent paper titled “Seed Train Optimization in Microcarrier-Based Cell Culture Post In Situ Cell Detachment through Scale-Down Hybrid Modeling” has offered a promising breakthrough that could significantly enhance the scalability and efficiency of viral vaccine - [Boosting Clinical Stem Cell Production: Smart MCs’ Leap Forward with TIA Grant](https://smartmcs.com.au/boosting-clinical-stem-cell-production-smart-mcs-leap-forward-with-tia-grant/) - Sydney’s biomaterials leader, Smart MCs PTY LTD, was selected fora notable grant from Therapeutic Innovation Australia (TIA) to explore the potential of novel microcarriers in scaling up the production of Mesenchymal Stem Cells (MSCs) for clinical use. This project is a collaborative effort with the team of Dr. Zlatibor Velickovic at Cell & Tissue Therapies - [Webinar: Advancements in Edible Microcarrier Technologies for Scaling Cultured Meat](https://smartmcs.com.au/advancements-in-edible-microcarrier-technologies-for-scaling-cultured-meat/) - [Different morphologies of HEK293T cells in various types of culture dishes](https://smartmcs.com.au/different-morphologies-of-hek293t-cells-in-various-types-of-culture-dishes/) - Human embryonic kidney 293 (HEK293) cells are widely utilised in research and bioprocessing industries, yet scaling up their growth poses significant challenges. Check out the 2020 study by Iuchi et al., published in Cytotechnology, which delves into the various morphologies of human embryonic kidney 293T cells in different culture dishes. This research underscores the vital - [Smart MCs and University of Sydney Establish Collaboration on Stem Cell Production Project!](https://smartmcs.com.au/university-of-sydney-and-smart-mcs-pty-ltd-establish-collaboration-on-stem-cell-production-project/) - In a significant leap towards advancing stem cell research and biotechnology, Smart MCs PTY LTD is thrilled to announce its collaboration with Associate Professor Khoon Lim on a groundbreaking project, “Designing Biofunctional Microcarriers for Stem Cell Expansion.” This initiative has successfully secured seed funding from the University of Sydney’s Faculty of Engineering Seed Funding Scheme. - [Microcarrier Innovations for Large-Scale MSCs Expansion](https://smartmcs.com.au/microcarrier-innovations-for-large-scale-mscs-expansion/) - Microcarrier Innovations: Paving the Way for Large-Scale Mesenchymal Stromal Cell Expansion A recent review published in the Journal of Trends in Biotechnology highlights the critical advancements and challenges in the field of mesenchymal stromal cell (MSC) expansion through microcarrier technology (Read More – DOI: 10.1016/j.tibtech.2024.01.001). With advancements in cellular therapy, the crucial need for large-scale - [Efficient SARS-CoV-2 VSV Vaccine Production in Stirred-Tank Bioreactors](https://smartmcs.com.au/efficient-sars-cov-2-vsv-vaccine-production-in-stirred-tank-bioreactors/) - Publication Title: “High-Titer Manufacturing of SARS-CoV-2 Spike-Pseudotyped VSV in Stirred-Tank Bioreactors: A Leap in Vaccine Production Technology“. DOI: 10.1016/j.omtm.2024.101189 In a significant advancement for vaccine production technology, a recent article published in the journal of Methods & Clinical Development (Cell Press) has outlined the efficacy of microcarrier systems in stirred-tank bioreactors for the production of - [AAV Production Using Microcarriers Shows Higher Viral Production Yield than Suspension Culture](https://smartmcs.com.au/aav-production-using-microcarriers/) - Production of recombinant adeno-associated virus vectors using microcarrier culture of HEK293T cells The study conducted by Yongfa Lan, HaiRui Yang, and QingRui You from Obio Technology, commissioned by Cytiva, presents a comprehensive comparison of producing adeno-associated virus (AAV) using different cell culture methods, specifically focusing on the use of microcarriers versus traditional flask culture and - [Prof. Steve Oh's Guide: Mastering Cell Therapy Development](https://smartmcs.com.au/prof-steve-ohs-guide-mastering-cell-therapy-development/) - Dive into the world of cell therapy development and manufacturing with the latest episode of Smart Biotech Scientist Podcast with our very own Prof. Steve Oh: This week, David was joined by Steve Oh, Scientific Advisor and ex-A*STAR Professor, who brings a wealth of knowledge from his extensive experience in biotechnology. Steve will offer his - [Happy New Year from Smart MCs Team](https://smartmcs.com.au/happy-new-year-from-smart-mcs/) - As we welcome 2024, we can’t help but reflect on the incredible year that was 2023. - [Economic Benefits of Microcarrier Technology in Mesenchymal Stem Cell Production](https://smartmcs.com.au/economic-benefits-of-microcarrier-technology-in-stem-cell-production/) - RoosterBio Inc. has published findings that herald a new era in the biomanufacturing of human mesenchymal stem cells (hMSCs). The study focuses on the implementation of microcarrier technology, which has been shown to significantly reduce the costs associated with MSC production. The white paper released by RoosterBio delves into the scalability of MSC cultivation using | RoosterBio Inc. has published findings that herald a new era in the biomanufacturing of human mesenchymal stem cells (hMSCs). The study focuses on the implementation of microcarrier technology, which has been shown to significantly reduce the costs associated with MSC production. The white paper released by RoosterBio delves into the scalability of MSC cultivation using | Stem Cell - [Large-scale microcarrier culture of HEK293T cells and Vero cells in single-use bioreactors](https://smartmcs.com.au/large-scale-microcarrier-culture-of-hek293t-cells-and-vero-cells-in-single-use-bioreactors/) - Source of Images and article: 10.1186/s13568-019-0794-5 A Study Shows Better Way to Make HEK Cells at large-scale for Gene Therapy and vaccine production Researchers, including Yang and others, have shared a new method that could make it easier to produce important cells used in gene therapy and viral vaccines. Their study shows how to grow - [Review Article - Scaling up stem cell production: harnessing the potential of microfluidic devices](https://smartmcs.com.au/review-article-scaling-up-stem-cell-production-harnessing-the-potential-of-microfluidic-devices/) - Smart MC’s latest review article, “Scaling up stem cell production: harnessing the potential of microfluidic devices,” published in the prestigious ‘Biotechnology Advances‘ journal, offers an informative and detailed examination of the role of microfluidic devices in stem cell manufacturing. This comprehensive review addresses the critical challenges currently faced in the stem cell industry, such as - [Podcast: Unveiling the Power of Microcarriers - Scaling Up Adherent Cell Cultures](https://smartmcs.com.au/podcast-unveiling-the-power-of-microcarriers-scaling-up-adherent-cell-cultures/) - Curious about elevating your cell culture game? Explore the advantages of microcarriers and adherent cell cultures versus traditional suspension cultures. Ready to redefine your bioprocess development strategy? In the latest episode, Dr. David Brühlmann invited Smart MCs’ CEO, Dr. Payar Radfar, to explore the world of adherent cell cultures. Smart MCs specializes in customized biomaterials - [Race for Sustainable Protein: Companies Compete to Develop the Superior Cultured or Artificial Meat](https://smartmcs.com.au/race-for-sustainable-protein-companies-compete-to-develop-the-superior-cultured-or-artificial-meat/) - A global competition conducted by XPRIZE titled ‘Feed the Next Billion’ (FTNB), has announced its six finalists for companies in the alternative meat industry. One notable finalist was CellX, a cultured-meat producer from China, which develops cultivated meat products on an international scale. - [Stiffness of Substrates Directs the Stem Cell Differentiation](https://smartmcs.com.au/stem-cell-differentiation-through-soft-or-stiff-substrates/) - Mesenchymal stem cells (MSCs) possess enormous potential as they can differentiate into various types of cells. This research sheds light on how external factors direct stem cells in tissue regeneration and their responses to mechanical stimuli. - [GEN News: Australia Boosts Bioprocessing with Government Grants](https://smartmcs.com.au/gen-news-australia-boosts-bioprocessing-with-government-grants/) - Article published by Genetic Engineering & Biotechnology News (GEN) placed Smart MCs in the spotlight as a key Australian player in the bioprocessing sphere. It discusses our company’s achievement securing a major government grant for an automated production line. - [Unleashing Global Potential: Smart MCs attends ISCT Paris 2023 Conference](https://smartmcs.com.au/unleashing-global-potential-smart-mcs-attends-isct-paris-2023-conference/) - Smart MCs has returned from the 2023 ISCT Conference held in Paris, France. With the aim to collaborate among industry leaders, discover new innovations in the field of life sciences, and explore new business opportunities for the company, this event proved to be highly fruitful for developing new possibilities in the field of biotechnology. - [Smart MCs Exhibiting at ISCT Paris 2023 Conference](https://smartmcs.com.au/smart-mcs-exhibiting-at-isct-paris-2023-conference/) - Smart MCs will be exhibiting at the International Society for Cell & Gene Therapy (ISCT) 2023 Global Conference, held in Paris, France. There we will be showcasing our research in biotechnology and our microcarrier products to other industry leaders. - [Smart MCs Receives Major Australian Government Grant to Establish $600k Advanced Microcarrier Production Line](https://smartmcs.com.au/smart-mcs-received-a-major-australian-government-grant-to-establish-600k-advanced-microcarrier-production-line/) - Smart MCs, a biotech startup born out of the University of Technology Sydney (UTS) ecosystem, has been awarded an Accelerating Commercialisation government grant for their scaled up microcarrier production line, a project totalling $600K. - [Microcarrier-Based Bioreactors Found to Offer More Efficient and Scalable Solution for Stem Cell Production](https://smartmcs.com.au/microcarrier-based-bioreactors-found-to-offer-more-efficient-and-scalable-solution-for-stem-cell-production/) - Leading scientists have outlined the benefits of Microcarriers in the process of cell-therapy applications compared totraditional planar cultures. When undertaking larger-scale production their adoption has seen to provide improved benefits in production and overall efficiency. - [The United States is accountable for 60% of the worldwide investment in lab-grown meat](https://smartmcs.com.au/the-united-states-is-accountable-for-60-of-the-worldwide-investment-in-lab-grown-meat/) - Coming in second is Israel, with a total of nine companies and £474.59 million raised for research, accounting for 21.72of the total global investment raised. - [The Prime Minister of Japan intends to establish a cultivated meat sector](https://smartmcs.com.au/japans-prime-minister-plans-to-develop-a-cultivated-meat-industry/) - He believes that foodtech, including cellular foods, is important in achieving a sustainable food supply. - [The world's first cultivated steak has been created by scientists.](https://smartmcs.com.au/the-worlds-first-cultivated-steak-has-been-created-by-scientists/) - A UK-based company has produced what they claim to be the first-ever cultivated steak fillet made using pork cells. - [Steakholder Foods® Receives Grant of up to $1M for Collaboration with Umami Meats to 3D Bio-Print Structured Cultivated Fish Products](https://smartmcs.com.au/steakholder-foods-receives-grant-of-up-to-1m-for-collaboration-with-umami-meats-to-3d-bio-print-structured-cultivated-fish-products/) - The company's collaborative initiative with its 3D bio-printer is a significant step forward in the company's commercialization strategy for 2023. - [Cultivated meat could become available in US dining establishments in 2023](https://smartmcs.com.au/cultivated-meat-could-become-available-in-us-dining-establishments-in-2023/) - Singapore is the only country to approve lab-grown meat for retail, but the US is to follow. FDA cleared Upside Foods' chicken breast for human consumption in November 2022. - [Pro. Steve Oh Scientific Advisor - Smart MCs](https://smartmcs.com.au/steve-oh/) - We are confident that Steve's unparalleled experience and achievements will make a valuable contribution to our company, and we are excited to have him join our team. - [World's biggest cultivated Meat factory is being built in US](https://smartmcs.com.au/worlds-biggest-cultivated-meat-factory-is-being-built-in-us/) - Believer Meats, known formerly as Future Meat, is looking to play a pivotal role in the availability of lab-grown meat products. - [New Year](https://smartmcs.com.au/new-year/) - On behalf of Smart MCs’ team, we would like to wish you a happy new year! May 2023 be full of joy and happiness for everyone. - [Smart MCs Completes Big Idea Ventures' Program](https://smartmcs.com.au/smart-mcs-completes-big-idea-ventures-program/) - Edible Microcarrier - Big Idea Ventures - Alternative Protein - Investor, leaders in the alternative protein sector, Startups and government officials - [American Chefs are betting on Cultivated Meat](https://smartmcs.com.au/american-chefs-are-betting-on-cultivated-meat/) - Chefs eagerly await cultivated meat as a greener, healthier, and more sustainable option that will meet diner's demand for the tastes and experiences they love. - [Jennifer Stojkovic’s experience at the historic GOOD Meat Cultivated Meat Testing at COP27](https://smartmcs.com.au/jennifer-stojkovics-experience-at-the-historic-good-meat-cultivated-meat-testing-at-cop27/) - Future of Food and General Partner of Joyful Ventures - 20% of all greenhouse gas emissions worldwide are attributed to animal agriculture. - [Smart MCs Presented in BPN Network – Sydney, 2022](https://smartmcs.com.au/bpn-network-2022/) - Industrial food and products - edible and digestible microcarriers for cultivated meat production. - Microcarrier limitations - Scaffolding - [Singapore International Agri-Food Week](https://smartmcs.com.au/singapore-international-agri-food-week/) - 07/01/2026 - Global Agri-Food Scientific Symposium - Haofood , Gaia foods - [UTS Vice Chancellor's Innovation Showcase 2022](https://smartmcs.com.au/uts-vice-chancellors-innovation-showcase-2022/) - Minister for Industry and Science Ed Husic - Australian Quantum Software Network (AQSN) - Australia’s quantum software research and development. - [FDA Gives Pre-Market Approval to UPSIDE Foods](https://smartmcs.com.au/fda-gives-pre-market-approval-to-upside-foods/) - FDA’s First green light to cultured meatHistory has been made! First move by FDA to take cultured meat from UPSIDE Foods to our dining tables. Read More on FDA website: FDA Completes First Pre-Market Consultation for Human Food Made Using Animal Cell Culture Technology. Before Entering the U.S. Market, the Food Must Meet Other Federal - [Cultivated Meat Being Served at COP27](https://smartmcs.com.au/cultivated-meat-being-served-at-cop27/) - Cultivated Chicken will be served!For the first time lab-grown meat will be served over United Nations’ Climate Change conference in Egypt. EAT JUST will be providing two cultivated chicken meals. “We hope our guests at COP27 find their cultivated chicken meals both delicious and thought-provoking and they leave the summit with a new appreciation for - [Smart MCs will be presenting at BIV Demo Day](https://smartmcs.com.au/smart-mcs-will-be-presenting-at-biv-demo-day/) - Big Idea Ventures' 2022 Demo Day - Singapore ## Pages - [Home](https://smartmcs.com.au/) - Smart Biomaterials & µ-Solutions Elevating your Bioproduction with Sophisticated Microcarriers, Hydrogels and µFluidic Solutions Discover MoreAbout UsAt Smart MCs, we’re reinventing the landscape of bioproduction and scientific inquiry by specialising in bespoke biomaterials and microfluidic solutions. Our focus is on crafting application-tailored solutions, moving away from generic, one-size-fits-all answers to complex biological challenges. Our Smart - [Microcarriers](https://smartmcs.com.au/microcarriers/) - CUSTOMISED & CELL TYPE SPECIFIC MICROCARRIERSSmart MCs specialise in developing customised microcarriers tailored to specific cell types and applications. Our microcarriers enable efficient and streamlined cell culture while minimising cell loss, resulting in cost-effective and high-yield expansion of cells. Smart MCs is revolutionising the field of cellular cultivation by developing custom microcarriers made from biodegradable - [Hydrogels](https://smartmcs.com.au/hydrogels-3/) - Fully Defined HydrogelsThe use of animal-derived hydrogels in bioproduction and research has long been fraught with challenges that compromise both reproducibility and customisability. The inherent variability of these biological materials can introduce unpredictable factors, thereby undermining the consistency and reliability of your experimental or production outcomes. Moreover, traditional animal-derived hydrogels often necessitate complex crosslinking methods, - [µFluidics](https://smartmcs.com.au/microfluidics/) - µFluidic Solutions At Smart MCs, our interdisciplinary team boasts a wealth of expertise in the cutting-edge fields of design, fabrication, and operation of microfluidic devices, specialising in a wide range of applications tailored to meet the intricate demands of modern biomedical research and industry. Microfluidics is not merely a buzzword; it’s a game-changing technology that - [Key Publications](https://smartmcs.com.au/key-publications/) - Key PublicationsMicrocarriers “Scaling up stem cell production: harnessing the potential of microfluidic devices”, Ding, Oh, Radfar & Warkiani et al., DOI: 10.1016/j.biotechadv.2023.108271, Biotechnology Advances, 2023. “Bioreactor-Based Adherent Cells Harvesting from Microcarriers with 3D Printed Inertial Microfluidics”, Ding & Warkiani et al., DOI:10.1007/7651_2021_444, Bioreactors in Stem Cell Biology, 2021. “Multiomics analyses of cytokines, genes, miRNA, and - [What Are Microcarriers?](https://smartmcs.com.au/what-are-microcarrier/) - What is Microcarrier? - What is Cell Culture? - Limiting factors with Scaled-up Cell Culture - Cultured Meat and issues with Microcarrier - [Scientific Webinars](https://smartmcs.com.au/scientific-webinars/) - Jane2025-09-30T16:45:14+10:00September’2025 – Scientific Webinar: Prof. Kristopher KilianJane2025-09-30T16:45:14+10:00September 3rd, 2025|We were pleased to host Prof. Kristopher Kilian from UNSW Sydney for our September webinar, where he presented on: Inspired by Nature: Biomaterials Design for Therapeutic Cell [...]Jane2025-07-29T16:38:08+10:00Smart MCs × TCS | July 2025 Scientific Webinar with Dr. Daniel PetersJane2025-07-29T16:38:08+10:00July 16th, 2025| Building a Molecular “Lego Set” - [Microcarrier Culture Tips](https://smartmcs.com.au/microcarrier-culture-tips/) - Jane2025-03-14T05:58:30+11:005 Essential Tips for Small-Scale Microcarrier CultureJane2025-03-14T05:58:30+11:00March 14th, 2025|Small-scale microcarrier cultures play a crucial role in process development, allowing researchers to refine conditions before scaling up to larger bioreactors. However, managing small-scale cultures requires careful [...]Jane2024-11-26T03:49:47+11:005 Essential Tips for Optimising Agitation in Your Microcarrier CultureJane2024-11-26T03:49:47+11:00November 26th, 2024| Agitation is a cornerstone of successful microcarrier-based cell - [Products](https://smartmcs.com.au/product/) - [News](https://smartmcs.com.au/news/) - Smart Biomaterials & µ-Solutions- Smart MCs - [Stem Cell Role in Regenerative Medicine](https://smartmcs.com.au/stem-cell-role-in-regenerative-medicine/) - Role of Mesenchymal Stem Cells Regenerative MedicineIntroduction In the rapidly evolving field of regenerative medicine, Mesenchymal Stem Cells (MSCs) stand at the forefront, offering promising therapeutic avenues. This article delves deep into two significant applications of MSCs: direct cell therapy for regeneration and exosome production for targeted organ repair. It also addresses the escalating need - [How Vaccine Production Works?](https://smartmcs.com.au/how-vaccine-production-works/) - HOw Vaccine Production Works?Introduction Vaccines are pivotal in public health, shielding us from numerous infectious diseases. This exploration into vaccine production underscores the significance of cell culture techniques, viral transfection, and notably, the role of microcarriers. Vaccine Production Overview Global vaccine production predominantly relies on traditional methods involving live-attenuated or inactivated pathogens, particularly crucial in - [What is Cultivated Meat?](https://smartmcs.com.au/what-is-cultivated-meat/) - Cultivated Meat definition - Benefits of Cultivated Meat - Cultivated Meat Market - ## Products - [P2 Microcarriers](https://smartmcs.com.au/product/p2-microcarriers/) - The P2 Microcarrier is a xeno-free and dissolvable biopolymer bead platform for cell culture, offering adjustable stiffness from 3kPa to 100kPa to suit various cell types and conditions. Beyond flexibility in stiffness, it can be customised in charge, size, and coatings to meet specific cell culture needs, ensuring optimal culture performance. - [Cell Strainer](https://smartmcs.com.au/product/cell-strainer/) - Cell Strainers deliver efficient and precise particle separation, perfectly fitting Falcon tubes and supporting applications across cell culture, isolation, and analytical research. Available pore sizes include 5 µm, 10 µm, 20 µm, 40 µm, 70 µm, 100 µm, 200 µm, 300 µm, and 420 µm. - [P1 Microcarriers](https://smartmcs.com.au/product/p1-microcarriers/) - The P1 Microcarrier is a fully defined and synthetic microcarrier for cell culture, offering adjustable stiffness from 3kPa to 100kPa to suit various cell types and conditions. Beyond flexibility in stiffness, it can be customised in charge, size, and coatings to meet specific cell culture needs, ensuring optimal culture performance. - [Hyaluronic Acid Methacryloyl (HAMA)](https://smartmcs.com.au/product/hyaluronic-acid-methacryloyl-hama/) - Hyaluronic Acid Methacryloyl features methacrylated hyaluronic acid alongside the photoinitiator LAP, tailored for use in cell culture, biological 3D printing, and tissue engineering among other scientific fields. It is strictly designed for scientific research and is not intended for human application. Custom modification to the gel can be provided upon request – including peptide or other hydrogel combination. - [Alginate Methacryloyl (AlgMA)](https://smartmcs.com.au/product/algma/) - Alginate Methacryloyl (AlgMA) is a modified form of sodium alginate that is designed to solidify into a gel when exposed to UV or visible light, using a photoinitiator. This innovative light-curing method offers superior portability and produces gels with excellent internal uniformity compared to traditional methods that use divalent ions such as calcium. The resulting AlgMA hydrogel features a three-dimensional structure that is conducive to cell growth and differentiation, and contains active chemical sites for further reactions. This hydrogel is particularly valuable in various biomedical applications. Custom modification to the gel can be provided upon request – including peptide or other hydrogel combination. - [Silk Fibroin Methacryloyl (SilkMA)](https://smartmcs.com.au/product/silk-fibroin-methacryloyl-silma/) - Silk Fibroin Methacryloyl comprises methacryloyl-modified silk fibroin and the photoinitiator LAP, tailored for applications in cell culture, biologic 3D printing, and tissue engineering. It is designated exclusively for scientific research and is not intended for human use. Custom modification to the gel can be provided upon request – including peptide or other hydrogel combination. - [Methacryloyl Gelatin (GelMA)](https://smartmcs.com.au/product/gelma/) - Gelatin Methacryloyl, referred to as GelMA (GM-30/60/90), comprises a kit containing methacrylated gelatin along with the photoinitiator LAP. This kit is engineered for specialized applications such as cell culture, biological 3D printing, and tissue engineering. Notably, this product is strictly intended for research use in scientific settings and is not suitable for clinical applications involving humans. Custom modification to the gel can be provided upon request - including: high porosity GelMA, fluorescent GelMA, peptide or other hydrogel combination. - [G1](https://smartmcs.com.au/product/g1/) - G1 Hydrogel is an animal-free hydrogel designed for simple, room-temperature operation. It gels instantly upon addition of your cell culture media, making it ideal for cell culture, regenerative medicine, tissue engineering, and biomedical research. Custom modification to the gel can be provided upon request – including peptide or other hydrogel combination. - [PLMA (poly-L-lysine methacrylate)](https://smartmcs.com.au/product/plma/) - Poly-Lysine Methacrylate (PLMA) features methacrylated poly-lysine tailored for antimicrobial wound dressings, antibacterial coatings, tissue engineering, and 3D bioprinting applications. It is strictly designed for scientific research and is not intended for human application. Custom modification to the gel can be provided upon request – including peptide or other hydrogel combination. - [Poly(ethylene glycol) diacrylate (PEGDA)](https://smartmcs.com.au/product/pegda/) - Polyethylene Glycol Diacrylate (PEGDA) features polyethylene glycol functionalised with acrylate groups, customisable for use in cell culture, biological 3D printing, tissue engineering, and photolithography applications. It is strictly designed for scientific research and is not intended for human application. Custom modification to the gel can be provided upon request – including peptide or other hydrogel combination. - [Hydrogel Screening Kit](https://smartmcs.com.au/product/hydrogel-screening-kit/) - Explore the versatility of hydrogels with the Hydrogel Screening Kit by Smart MCs, designed to offer researchers a comprehensive set of hydrogel formulations for varied applications. This kit includes small samples of GelMA, AlgMA, SilkMA, and HAMA—perfect for conducting multiple tests and optimizing your research outcomes. Custom modifications to the gel can be provided upon request, including high porosity GelMA, fluorescent GelMA, peptide, or other hydrogel combinations. - [Smart Emulsifier](https://smartmcs.com.au/product/smart-emulsifier/) - Smart Emulsifier by Smart MCs is a cutting-edge droplet generation oil designed to replace expensive fluorinated oils, delivering the same precise monosize droplet generation and stability at a fraction of the cost. This ready-to-use solution is ideal for a wide range of applications, offering both efficiency and reliability for modern lab processes. - [Large Culture Vessel](https://smartmcs.com.au/product/large-culture-vessle/) - An advanced laboratory culture vessel designed for seamless scaling of microcarrier-based and suspension cell cultures, featuring a built-in mixing unit that eliminates the need for external magnetic stirrers. Designed to fit inside an incubator, it provides smooth, controlled agitation for optimal cell growth and improved yields. With a wide speed range, including low RPM settings as little as 30 RPM, it ensures gentle mixing ideal for delicate cell cultures. Available in 1L to 5L volumes, this cost-effective alternative to expensive bioreactors offers a practical and scalable solution for research and production applications. - [Orbital Shaker](https://smartmcs.com.au/product/orbital-shaker/) - The Orbital Shaker offers precise control, reliable mixing performance, and quiet operation, perfectly suited for diverse laboratory mixing applications and high-throughput processing. - [Magnetic Stirrer](https://smartmcs.com.au/product/magnetic-stirrer/) - The Magnetic Stirrer provides precise, reliable stirring, ideal for cell culture and general laboratory use, perfectly complementing spinner flask systems for optimal cell growth and uniform solution preparation. - [Non-Adherent Coating](https://smartmcs.com.au/product/non-adherent-coating/) - Smart MCs' Non-Adherent Coating provides reliable, uniform, and efficient surface coating, essential for precise cell culture experiments, particularly in microcarrier-based systems. - [Monodisperse Microspheres](https://smartmcs.com.au/product/monodisperse-microspheres/) - Our extensive range of microbeads, including magnetic and antibody-coated beads, supports diverse applications from cell separation to particle filtration, available in sizes from 20 nm to 1000 µm depending on material and requirement. - [Syringe Filter](https://smartmcs.com.au/product/syringe-filter/) - Sterile Syringe Filters provide reliable, efficient sterilization and particle removal, essential for maintaining sample integrity and ensuring accuracy in scientific and clinical applications. Available in 0.22 µm and 0.45 µm - [Magnetic Spinner Flask](https://smartmcs.com.au/product/magnetic-spinner-flask/) - An advanced laboratory vessel designed for seamless scaling of microcarrier-based cell cultures and suspension cultures, providing smooth and consistent agitation through a magnetic stir bar. Ideal for scaling from traditional T-Flasks or roller bottles to spinner systems, it ensures optimal cell growth conditions and improved yields. Works best with the recommended magnetic stirrer. - [X1 Microcarrier](https://smartmcs.com.au/product/x1-microcarrier/) - The X1 Microcarrier is a top performing, versatile, gelatin-based platform for cell culture, offering adjustable stiffness from 3kPa to 100kPa to suit various cell types and conditions. Beyond flexibility in stiffness, it can be customised in charge, size, and coatings to meet specific cell culture needs, ensuring optimal culture performance. - [Organ-on-a-chip Devices](https://smartmcs.com.au/product/organ-on-a-chip-devices/) - At Smart MCs, we provide cutting-edge technology of organs-on-chips (OoCs), offering versatile microfluidic systems to model the tissue microenvironment accurately. Our organ-on-a-chip systems simulate the activities, mechanics, and physiological responses of human organs, providing an advanced in vitro alternative for drug development, toxin testing, and the study of disease pathophysiology. - [Micromixers](https://smartmcs.com.au/product/micromixers/) - Smart MCs introduces advanced micromixers, essential devices engineered for precision fluid mixing at the micron scale. Catering to the chemical, pharmaceutical, analytical chemistry, and biotechnology industries, our micromixers leverage mechanical micro-parts to revolutionize mixing efficiency and reduce material use in various processes. Whether it's for antibody binding, enzyme treatments, or high-throughput synthesis, our customizable solutions meet the diverse needs of modern scientific endeavors. - [Droplet Microfluidic Devices](https://smartmcs.com.au/product/droplet-microfluidic-devices/) - Droplet-based microfluidics, a revolutionary technology in the realm of lab-on-a-chip devices, manipulates tiny fluid volumes to perform high-throughput, precision experiments with minimal reagent use. This technique, essential for isolating single cells, protein crystallization, and DNA sequencing, offers a shear-free environment conducive to delicate biological studies. Its application in directed evolution, chemical synthesis, and gel particle formation marks a significant advancement in biotechnology, pharmaceuticals, and materials science. Smart MCs can provide you with droplet microfluidic devices to meet your needs. Get in touch with us to discuss your needs in more details - [Micron-Particle Sorting](https://smartmcs.com.au/product/micron-particle-sorting/) - Harnessing the precision of inertial microfluidics, we provide a suite of devices tailored for the size-based separation of particles ranging from 3 to over 100 microns. Our technology stands out for its ability to purify biological samples efficiently in a shear-free and high-throughput manner, making it an essential tool for both fundamental research and custom workflow integration. - [Cell Harvester: Dewatering Unit](https://smartmcs.com.au/product/cell-harvesting/) - Our device is engineered to transcend traditional cell processing, offering a label-free, high-throughput solution for a myriad of applications. It's perfect for integrating with perfusion bioreactor systems, dramatically simplifying the cell harvesting process. Additionally, it serves as an essential tool for reducing sample volumes, facilitating easier and less stressful centrifugation. Beyond these applications, it offers a passive approach that allows for the effortless exchange of media in ongoing cultures, ensuring cells remain nourished without interruption. This device is the key to efficient, gentle, and continuous cell processing. - [Pathogen Purification](https://smartmcs.com.au/product/pathogen-purification/) - Smart MCs harnesses the precision of inertial microfluidics to offer cost-effective, high-throughput, and shear-free purification of biological samples. Our tools excel in separating micron-sized particles by size, overcoming common obstacles like debris contamination and the presence of unwanted cells or parasites from human and animal samples. - [Label-Free Circulating Tumour Cell Isolation](https://smartmcs.com.au/product/label-free-circulating-tumour-cell-sorting/) - This Cell Sorting Device offers a user-friendly microfluidic device for label-free sorting of Circulating Tumor Cells (CTCs) from various bodily fluids. It simplifies and expedites the cell sorting process in both clinical and research settings without complex procedures. ## MailPoet Page - [MailPoet Page](https://smartmcs.com.au/?mailpoet_page=captcha) - [mailpoet_page] - [MailPoet Page](https://smartmcs.com.au/?mailpoet_page=subscriptions) - [mailpoet_page] ## Fusion Elements - [Introduction - Team](https://smartmcs.com.au/fusion_element/introduction-team/) - [microcarrier](https://smartmcs.com.au/fusion_element/microcarrier/) ## Categories - [Uncategorized](https://smartmcs.com.au/category/uncategorized/) - [Conference & Presentations](https://smartmcs.com.au/category/conference-presentations/) - [General News](https://smartmcs.com.au/category/general-news/) - [Smart MCs' News](https://smartmcs.com.au/category/smart-mcs-news/) - [Knowledge Centre](https://smartmcs.com.au/category/knowledge-centre/) - [Microcarrier Culture Tips](https://smartmcs.com.au/category/knowledge-centre/microcarrier-culture-tips/) - [Webinars](https://smartmcs.com.au/category/knowledge-centre/webinars/) ## Tags - [Stem Cells](https://smartmcs.com.au/tag/stem-cells/) - [Microcarriers](https://smartmcs.com.au/tag/microcarriers/) ## Product categories - [Microcarriers](https://smartmcs.com.au/product-category/microcarriers/) - [Hydrogels](https://smartmcs.com.au/product-category/hydrogels/) - [Microfluidics](https://smartmcs.com.au/product-category/microfluidics/) - [Reagents and Consumables](https://smartmcs.com.au/product-category/reagents-and-consumables/) - [Laboratory Equipment](https://smartmcs.com.au/product-category/laboratory-equipment/)